Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma: a phase II trial of the AIO study group (AIO STO 0321) - Tintelnot, Joseph; Stein, Alexander; Batran, Salah-Eddin al-; Ettrich, Thomas J.; Götze, Thorsten; Grün, Barbara; Haag, Georg Martin; Heuer, Vera; Hofheinz, Ralf-Dieter; Homann, Nils; Bröring, Tobias Sebastian; Cruz, Mariana Santos; et al. (Frontiers in oncology, 2023)
Gesehen am 13.12.2023